Because obesity is so difficult to treat, the introduction of GLP-1 receptor agonists marked an important inflection point in management
Some users experience mild nausea, slight constipation, or a change in food preferencesespecially away from high-fat or sugary options
it doesnt permanently alter energy balance or metabolic rate
Respondents of the November/December survey from Diabetes Canada also reported comorbidities alongside their diabetes, including weight management issues (79%), high blood pressure (64%), mental health concerns (43%), abnormal cholesterol levels (29%) and eye problems (29%)
typically resolves with proper technique
During your consultation, Kristina reviews your medications, supplements, and lifestyle to flag anything that could interfere with the infusion